about
Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS.A cluster randomised controlled trial of the clinical and cost-effectiveness of a 'whole systems' model of self-management support for the management of long- term conditions in primary care: trial protocol.A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis.Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trialIdentifying variation in models of care for the genomic-based diagnosis of inherited retinal dystrophies in the United Kingdom.Workload in community pharmacies in the UK and its impact on patient safety and pharmacists' well-being: a review of the evidence.Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example.Critical points for an accurate human genome analysis.Workload pressure among recently qualified pharmacists: an exploratory study of intentions to leave the profession.Valuing Preferences for the Process and Outcomes of Clinical Genetics Services: A Pilot Study.Patients' experiences of shared decision making in primary care practices in the United kingdom.What are colorectal cancer survivors' preferences for dietary advice? A best-worst discrete choice experiment.Cost effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER).Valuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation methodToward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions
P50
Q30626900-4422D9E5-E0B9-4717-B2DB-06F27FEF997AQ35742252-244C98E0-9AE0-4CE3-ABD3-A7D84BFF1FA8Q35895550-BFE05849-5D5E-4ED4-9811-B1A379D18638Q36839793-1D08E0C5-9340-4A53-8882-8ABFF278ACF2Q37085407-0DA4A737-B963-439A-A9C5-D8EFF4DC3C1AQ37882029-90428E63-3A17-4801-A1D3-4592CA17E3A7Q38744128-56834227-B51C-46AA-AFCD-FFF91E363D04Q39283243-803D1603-221A-4499-A156-99D26223853EQ39893276-5AC8F2CF-2FB6-4A18-B73D-B57DDF5C8DF7Q40825708-0E72A2D7-25C4-4138-BECD-679601B0813EQ42675395-8C9EA82D-4B7C-448E-89BB-76EE37C9371CQ47102725-93AAD304-8C87-4C54-890B-0BDA7AFD0052Q53290843-0DBA28F0-66ED-4C38-A047-FF13EEA329B5Q57206612-41AE38C4-D037-419D-A4EC-BB6F82E8C04EQ57697360-E612C20C-FDB6-4447-97DF-B90456EF599E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin Eden
@ast
Martin Eden
@en
Martin Eden
@es
Martin Eden
@nl
Martin Eden
@sl
type
label
Martin Eden
@ast
Martin Eden
@en
Martin Eden
@es
Martin Eden
@nl
Martin Eden
@sl
prefLabel
Martin Eden
@ast
Martin Eden
@en
Martin Eden
@es
Martin Eden
@nl
Martin Eden
@sl
P214
P106
P214
P31
P496
0000-0002-1542-2527
P734
P735
P7859
viaf-218142680